Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, α-interferon (leucocyte) and tamoxifen
2000
Survival in renal cell carcinoma: tamoxifen vs interleukin-2 and α-interferon
publication
Author Information
Primary Institution: Cancer Research Campaign
Takeaway
This study looks at how well different treatments work for kidney cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website